Expert consensus on the clinical application of platinums in advanced breast cancer (2020 version).

VernacularTitle:铂类药物晚期乳腺癌应用专家共识(2020版)
Collective Name:Breast Cancer Group, Branch of Oncologist, Chinese Medical Doctor Association
Publication Type:Journal Article
Keywords: Breast neoplasms, advanced; Clinical application; Expert consensus; Platinum
MeSH: Breast Neoplasms/drug therapy*; Consensus; Female; Humans; Platinum
From: Chinese Journal of Oncology 2021;43(2):167-175
CountryChina
Language:Chinese
Abstract: Breast cancer is the most common and fatal malignant tumor in women, which causes great social burden throughout the world. At present, chemotherapy is still the most important treatment manner of advanced breast cancer, and platinum drugs are one of the commonly used chemotherapeutic drugs. Based on the substantial evidence, the expert committee deeply discusses the clinical application of platinum drugs in advanced breast cancer, gives the reasonable suggestions for its clinical usage, effectiveness and adverse effects. This consensus aims to guide physicians to use drugs reasonably and standardize the diagnosis and treatment.